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Edited by Gianni CesareniAbstract Talin binding of integrins, via its band 4.1, ezrin, ra-
dixin, and moesin (FERM)-homologous domain, directly acti-
vates the integrin receptor. However, it is not known whether
other FERM-containing proteins also possess such an integrin
activating capability. We report here that radixin, one of the ori-
ginal FERM-domain proteins, binds to the membrane-proximal
region of the integrin b2 but not aM cytoplasmic tail. Impor-
tantly, we show that radixin binding signiﬁcantly enhances the
adhesive activity of integrin aMb2. Given the distinct biological
activities of radixin and talin, radixin may represent a novel
talin-independent pathway for integrin activation under speciﬁc
settings.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Recent studies suggest that talin binding to the cytoplasmic
domain of integrin receptors represents the ﬁnal step in inte-
grin activation (‘‘inside-out’’ signaling) [1]. Talin comprises
of an N-terminal 50-kDa head region that is homologous to
the FERM domain, and a C-terminal 205-kDa rod region,
which regulates the function of the N-terminal head via intra-
and inter-molecular interactions. Talin can be activated by cal-
pain-mediated proteolysis [2] or by phosphoinositide binding
[3], and once activated, it binds, through the phosphotyrosine
binding (PTB) domain located within its FERM-homologous
region, to a highly conserved NPxY motif within the integrin
b cytoplasmic tail [4,5]. Integrin engagement by talin subse-
quently disrupts a salt bridge between its a and b cytoplasmicAbbreviations: C-ERMAD, C-terminal ezrin–radixin–moesin family
(ERM) associated domain; CHO, Chinese hamster cells; ERM, the
ezrin–radixin–moesin protein family; ERMAD, ERM-associated
domain; FERM, the band 4.1, ezrin, radixin, and moesin-homologous
domain; Fg, ﬁbrinogen; GFP, green ﬂuorescent protein; HRP, horse-
radish peroxidase; ICAM-1, intercellular adhesion molecule-1; N-E-
RMAD, N-terminal ezrin–radixin–moesin family (ERM) associated
domain; PBS, phosphate buﬀered saline; PTB, phosphotyrosine bind-
ing domain; GST, glutathione-s-transferase; SDS–PAGE, sodium
dodecyl sulfate polyacrylamide gel electrophoresis
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doi:10.1016/j.febslet.2007.02.013domains [6], leading to its activation [5]. Interestingly,
although a number of proteins, including syk, Numb, and
Dok, contain a PTB domain that interacts with the integrin
b cytoplasmic tail with high aﬃnity, however, none of them
was capable of activating integrin receptor [5]. Thus, the talin
FERM domain seems very unique in its integrin activating
capability.
In this study, we searched for additional proteins that are
capable of activating integrins. We report here the identiﬁca-
tion of another FERM protein radixin that possesses similar
integrin activating activities. Using aMb2 (Mac-1, CD11b/
CD18) as a representative of integrin receptors, we demon-
strate that radixin binds to the membrane-proximal region of
the integrin b cytoplasmic tail via its N-terminal ezrin–radix-
in–moesin family (ERM) associated domain (N-ERMAD).
We show that radixin binding to integrin aMb2 enhances its
adhesive activity. Together, our study identiﬁes radixin as an
important player in integrin ‘‘inside-out’’ signaling in addition
to talin. As radixin recognizes the integrin cytoplasmic tail dif-
ferently than talin, radixin may represent a novel talin-inde-
pendent pathway for integrin activation under speciﬁc settings.2. Materials and methods
2.1. Materials
MGIN [7] was provided by Dr. R.G. Hawley (American Red Cross,
Rockville, MD). IB4, OKM1, and TS1/18 were from ATCC (Rock-
ville, MD); mAb 44 and 2LPM19c were from Sigma (St. Louis,
MO). mAb 24 [8] was provided by Dr. Nancy Hogg (Imperial Cancer
Research Fund, London, UK). Recombinant c-module of ﬁbrinogen
(Fg) was provided by Dr. L. Medved (University of Maryland,
MD). Neutrophil inhibitor factor (NIF) [9] was provided by Dr. E.
Plow (Cleveland Clinic Foundation, OH). All other reagents were of
the highest grade available from Sigma Chemical Co. (St Louis,
MO) unless otherwise noted.2.2. Expression of recombinant radixin in E. coli
To express the radixin N-ERMAD (1–298) and C-ERMAD (281–
584) in E. coli, their corresponding cDNAs were ampliﬁed using the fol-
lowing pairs of primers: 5 0-AAAGGATCC-ATGCCGAAGCCAAT-
CAATGTAAGAGT-3 0 and 5 0-TCAGTCGACTT-AATCAGGCTTT-
CTCCTTCGCATGTACAG-3 0, and 5 0-AAAGGATCCTTGGCCT-
TATGTATGG-GAAACATGAA-30 and 5 0-GAAGTCGACTCA-
CATGGCTTCAAACTCATCGATGCG-3 0, and then cloned into
pGEX-4T-1 (for glutathione-s-transferase (GST) fusion; Amersham,
Piscataway, NJ) and pET-32a (for histidine-tag fusion; Novagen, Mad-
ison,WI). Cytohesin-1 was expressed as a histidine-tagged protein using
pQE-31 (QIAgen). Generation of recombinant proteins in E. coli
BL21(DE3) and their puriﬁcation using the glutathione–Sepharose or
Ni–NTAcolumnhave been described previously [9]. The concentrations
of the puriﬁed proteins were determined spectrophotometrically usingblished by Elsevier B.V. All rights reserved.
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Fig. 1. Radixin N-ERMAD interacts with the integrin b cytoplasmic
tail. (A) Radixin N-ERMAD recognizes the b2 cytoplasmic domain. A
96-well plate was coated with either the aM (s, n) or b2 cytoplasmic
peptides (d, m), blocked, and then incubated with GST-radixin N-
ERMAD (s, d) or GST-C-ERMAD (n, m). After washing, bound
proteins were determined. (B) Radixin C-ERMAD blocks N-ERMAD
binding to the b2 cytoplasmic tail. Binding of radixin N-ERMAD to
the aM (ﬁlled bar) or b2 (open bar) peptides were conducted as
1104 P. Tang et al. / FEBS Letters 581 (2007) 1103–1108the equation C (mg/ml) = (A280–A320)/1.45 and the concentrations
were further veriﬁed by Coomassie blue-stained SDS–PAGE using
BSA as a standard.
2.3. Binding assays by ELISA
Ninety six-well polystyrene microtiter plates (Costar, Corning, NY)
were coated with diﬀerent synthetic peptides (1 mg/ml) overnight at
4 C and post-coated with 10% milk for 1 h at room temperature.
GST-tagged radixin fragments or His-tagged cytohesin-1 (both at
150 nM) in phosphate buﬀered saline (PBS) plus 0.1%BSA were added
and incubated for 40 min at room temperature. After washing with
PBS, bound GST-radixin was detected using a horseradish peroxidase
(HRP)-anti-GST conjugate, and an HRP substrate 3,3 0,5,5 0-tetrameth-
ylbenzidine, measuring absorption at 550 nm (A550).
2.4. Pull down assays
Cells expressing aMb2, which were established previously [10], were
lysed in 20 mM Tris–HCl, 150 mMNaCl, pH 7.4, 0.25% deoxycholate,
1% p-nitrophenyl-p-guanidinobezoate, 2 mM EGTA, 1 mM PMSF,
10 mM benzamidine, 25 lg/ml SBTI, and 20 lg/ml leupeptin. After
centrifugation, cell lysates were incubated with GST-radixin N-ER-
MAD that was immobilized onto a glutathione agarose column. After
washing, bound proteins were eluted and then analyzed by 10% SDS–
PAGE. The presence of aMb2 was detected by immunobloting using an
anti-b2 cytoplasmic domain antibody [11] and visualized using an HRP
conjugate of goat anti-rabbit IgG.
2.5. Establishment of Chinese hamster cells (CHO) expressing both
integrin aMb2 and radixin
To express aMb2 and radixin simultaneously, cDNAs encoding N-
ERMAD and C-ERMAD were inserted individually into the expres-
sion vector MGIN [7], in which radixin expression is tightly linked
to green ﬂuorescent protein (GFP) expression via an internal ribosome
entry site (IRES). These expression plasmids were transfected, together
with a expression vector containing the hygromycin cDNA, into the
aMb2-expressing CHO cells that we previously established [10]. After
selection with 200 lg/ml hygromycin, stable clones that express equiv-
alent amount of aMb2 and radixin were established by dual-color cell
sorting using a mAb anti-aM (OKM1) and GFP as cell sorting mark-
ers.
2.6. Cell adhesion assays
Cell adhesion was conducted using Fg or its aMb2-recognition do-
main, the c-module [10,12], based on our published procedures [13].
described above, except that diﬀerent concentrations of His-tagged
radixin C-ERMAD were added. Data are means ± S.D. of duplicate
samples and are representative of three independent experiments.3. Results
3.1. The N-terminal FERM domain of radixin interacts with the
b2 cytoplasmic tail
To see if talin is the only FERM domain-containing protein
that is capable of activating integrins, we tested the ability of
radixin to interact with the b2 integrin cytoplasmic tail. Given
that radixin exists in an inactive state due to an intramolecular
interaction between its N- and C-terminal ERMADs [14], we
expressed N-ERMAD (residues 1–298) and C-ERMAD (resi-
dues 281–584) separately as either GST- or His-tagged proteins.
All of the recombinant proteins exhibited expected molecular
sizes and were more than 90% pure (data not shown).
Interactions between radixin fragments and integrin cyto-
plasmic tails were assessed by ELISA. Thus, 96-well microtiter
plates were coated with aM (CYKLGFFKRQYKDMM-
SEGGPPGAEPQ) or b2 (CWKALIHLSDLREYRRFEK-
EKLKSQWNNDNPLFKSATTTVMNPKFAES) cytoplas-
mic peptides. Diﬀerent concentrations of radixin fragments
were added and bound proteins were quantiﬁed. As shown
in Fig. 1A, N-ERMAD bound the b2 cytoplasmic peptide
dose-dependently with a Kd of 110 ± 27 nM, whereas no signif-icant binding activity was observed for C-ERMAD. Moreover,
neither radixin fragments interacted with the aM cytoplasmic
peptide. Furthermore, no binding to an irrelevant peptide
SW63 (CSTHFPGGGSISHSGHF) or a scrambled peptide
sCTD31 (CLYRLEWFHAILRSRKD) was observed for N-
ERMAD (data not shown), verifying the speciﬁcity of the
binding assay. These data demonstrated that radixin recog-
nizes the b2 integrin cytoplasmic tail via its N-terminal FERM
domain.
3.2. Inhibition of N-ERMAD binding to integrin cytoplasmic
domain by C-ERMAD
To see if N-ERMAD binding to the integrin b2 cytoplasmic
domain is controlled by C-ERMAD, we conducted the above
binding assays in the presence of His-tagged C-ERMAD.
Addition of C-ERMAD at ratios of 2:1 and 4:1 (C-ER-
MAD:N-ERMAD) both led to signiﬁcant inhibition on N-
ERMAD binding to the b2 cytoplasmic peptide (Fig. 1B). As
expected, N-ERMAD did not interact with the aM cytoplasmic
tail with or without C-ERMAD.
P. Tang et al. / FEBS Letters 581 (2007) 1103–1108 11053.3. Radixin binds to the membrane-proximal region of the
integrin b2 cytoplasmic tail
To localize the functional sequence within the integrin b2
cytoplasmic tail for radixin recognition, we tested N-ERMAD
binding to truncated b2 cytoplasmic peptides (Fig. 2A). We
found that removal of NPxY/F, the sequence recognized by ta-
lin, did not signiﬁcantly aﬀect N-ERMAD binding as both
truncated b2 peptides CTD19 and CTD31 bound N-ERMAD
well (Fig. 2B). In fact, they exhibited higher binding activity
toward N-ERMAD than the full length peptide. Verifying
speciﬁcity, N-ERMAD did not bind to either the scrambled
peptide sCTD31 or BSA-coated wells.
To further conﬁrm the involvement of the membrane-prox-
imal region of the b2 cytoplasmic tail in radixin recognition,
the ability of soluble CTD31 to inhibit N-ERMAD binding
of the full length b2 cytoplasmic peptide was tested. Thus,
N-ERMAD was added to b2 peptide-coated 96-well plates inCWKALIHLSDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES
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Fig. 2. Radixin recognizes the membrane-proximal region of the
integrin b2 cytoplasmic tail. (A) The sequence of the b2 cytoplasmic
peptides. (B) Radixin N-ERMAD binds to the membrane-proximal
region of the b2 cytoplasmic tail. Interaction between the diﬀerent b2
cytoplasmic peptides and radixin N-ERMAD were determined by
ELISA as above. (C) Inhibition of N-ERMAD binding to the b2
cytoplasmic peptide by CTD31. Radixin N-ERMAD binding to the b2
cytoplasmic tail was performed as above, except in the presence
diﬀerent soluble peptides. Data are means ± S.D. of duplicate samples
and are representative of two independent experiments. sCTD31,
scrambled CTD31.the presence of diﬀerent concentrations of CTD31. After wash-
ing, bound N-ERMAD was determined as above. Fig. 2C
shows that CTD31, which contains only the membrane-proxi-
mal 16 residues, competed eﬀectively with the full length b2
peptide for radixin binding with a C50 of 25 lM, whereas its
scrambled control peptide sCTD31 or DMSO had no eﬀect.
Together, these data demonstrated that the NPxY/F sequence
within the b2 cytoplasmic domain, which is critical to talin rec-
ognition, is not required for radixin binding.
3.4. Radixin and cytohesin-1 recognize overlapping binding sites
within the b2 cytoplasmic tail
Cytohesin-1 activates aLb2 by binding to residues 723–731 of
b2 [15]. To see if cytohesin-1 and radixin share a common rec-
ognition site within b2, we conducted additional binding exper-
iments. Fig. 3A shows that cytohesin-1 binding to the full
length b2 peptide was eﬀectively inhibited by soluble CTD31
in a dose- dependent manner, whereas additions of similar con-
centrations of DMSO or an irrelevant peptide SW63 had no
eﬀect and addition of (sCTD31) yielded much weaker inhibi-
tion.
To further conﬁrm that radixin and cytohesin-1 recognize an
overlapping site within the b2 cytoplasmic tail, we tested ifCytohesin-1 (μM)
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Fig. 3. Cytohesin-1 and radixin N-ERMAD recognize overlapping
regions of the b2 cytoplasmic tail. (A) Cytohesin-1 binding to the b2
cytoplasmic tail. His-cytohesin-1 binding to the b2 cytoplasmic tail in
the presence of diﬀerent b2 peptides was performed as above. (B)
Competition between Cytohesin-1 and radixin. Binding of GST-
radixin N-ERMAD to the b2 cytoplasmic tail was conducted as in
Fig. 1 except in the presence of His-tagged cytohesin-1 (h) or a control
protein BSA (s). Data are means ± S.D. of duplicate samples and are
representative of two independent experiments.
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Fig. 4. Expression of the N-terminal radixin promotes integrin adhesive activity. (A) Pull-down assays. Cell lysates from aMb2-expressing CHO cells
were passed through either GST-N-ERMAD (lanes 1 and 3) or GST (lanes 2 and 4)-column. After washing, the bound proteins were analyzed by
SDS–PAGE and immunoblotted with anti-b2 cytoplasmic tail (lanes 1 and 2) or anti-GST (lanes 3 and 4). (B) The eﬀect of radixin N-ERMAD on
cell adhesion. Diﬀerent radixin fragments were expressed in aMb2/CHO cells and their adhesion to the Fg c-module (10 lg/ml) was determined in the
presence or absence of an aMb2-speciﬁc inhibitor NIF (10 nM). After washing, representative adherent cells were photographed with 20· diﬀerential
interference contrast (DIC) lens using the Zeiss Axiovert 200M system. Scale bars: 20 lm. (C) The numbers of adherent cells in (B) were quantiﬁed by
staining with Crystal violet and measuring absorption at 570 nm. The speciﬁcity of the adhesion assay was conﬁrmed by lack of cell adhesion of mock
transfected cells. (D) Conformational changes within the aMb2 receptor. aMb2/CHO cells expressing either N-ERMAD or GFP were incubated
with 1 lg of mAb 24 at 37 C or 2LPM19c in the presence of 1 mM Ca2+/1 mM Mg2+ for 30 min. Bound mAb 24 or 2LPM19c was determined by
ﬂow cytometry using R-Phycoerythrin conjugated anti-mouse IgG. An isotype matched non-immune IgG was used as a control (not shown). Mean
ﬂuorescence intensity of mAb 24, calculated using a FACScan program (BD Biosciences, Mountain View, CA) and normalized by surface expression
of the receptor (based on 2LPM19c staining), was used as an activation index. N-ERMAD-expressing aMb2/CHO cells exhibited signiﬁcantly higher
mAb 24 binding compared to those expressing GFP (*, P = 0.002). Data are means ± S.D. of duplicate samples and are representative of three
independent experiments.
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β2 CT:   WKALIHLSDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES 
ICAM-2 CT: WHRRRTGTYGVLAAWRRL 
A
B
Fig. 5. The integrin b2 cytoplasmic domain binding site within the radixin FERM domain. (A) Sequence alignment between the cytoplasmic domains
of ICAM-2 and integrin b2. Functional residues that are conserved between these two proteins are shown in boxes. (B) The b2 binding site within the
radixin FERM domain. A schematic drawing of the b2 cytoplasmic tail/radixin FERM complex was prepared from the crystal structure of the
radixin/ICAM-2 complex [22]. The b2 peptide is represented in red. The radixin FERM domain is composed of three subdomains: Fl (in cyan), F2 (in
orange) and F3 (in green). The conserved residues are shown in balls and sticks.
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for binding to the b2 cytoplasmic peptide. We found that in-
deed cytohesin-1 competed with radixin N-ERMAD eﬀectively
with a C50 of 0.2 lM, whereas addition of BSA did not have
signiﬁcant eﬀect (Fig. 3B).
3.5. Radixin binds integrin aMb2 in total cell lysates
To test if radixin interacts with integrin receptors in whole
cell lysates, we carried out pull-down experiments between ra-
dixin N-ERMAD and aMb2, a major b2 integrin expressed on
leukocytes. Fig. 4A shows that radixin N-ERMAD but not
GST, both of which were immobilized onto glutathione–Se-
pharose resin, could eﬀectively pull down aMb2, as demon-
strated by the presence of a 95 kDa protein by immunoblot
using anti-b2 polyclonal antibody. Additional immunoblot
analyses of the pull-down products with anti-GST antibody
veriﬁed that equally amount of GST and GST-N-ERMAD
were present on the resin.
3.6. Radixin promotes integrin adhesive activity
To test if radixin binding to the b2 cytoplasmic domain
could result in integrin activation, we transfected N-ERMAD
or C-ERMAD of radixin into aMb2-expressing CHO cells,
using the retroviral vector MGIN [7]. Stable cell lines that
express equivalent levels of aMb2 on the cell surface and similar
levels of radixin were established by cell sorting using both the
aM-speciﬁc mAb OKM1 and GFP as markers. Surface expres-
sion of aMb2 by the diﬀerent clones and also pools of the aMb2/
radixin/CHO cells used in this study diﬀered by less than two-
fold (mean ﬂuorescence intensity: 1594 for GFP, 1433 for C-
ERMAD pool, 1035 for N-ERMAD clone 6, and 2555 for
N-ERMAD pool). Cell adhesion experiments demonstrated
that expression of radixin N-ERMAD in aMb2/CHO cells sig-niﬁcantly increased the adhesive activity of aMb2 toward the
Fg c-module, a representative aMb2 ligand (Fig. 4B). Expres-
sion of radixin N-ERMAD increased the number of adherent
aMb2/CHO cells more than threefold when compared to that
of GFP (radixin vs. GFP, P < 0.005), whereas expression of ra-
dixin C-ERMAD had no eﬀect (Fig. 4C). Verifying speciﬁcity
of the adhesion assays, addition of EDTA or NIF, a high aﬃn-
ity aMb2-speciﬁc inhibitor [9], completely blocked the aMb2-
mediated cell adhesion. Moreover, no signiﬁcant adhesion to
the Fg c-module was observed for mock-transfected CHO cells
(Fig. 4C). Finally, to investigate whether radixin N-ERMAD
promoted the adhesive activity of aMb2 by changing its confor-
mation, we conducted FACS analyses using an activation-spe-
ciﬁc mAb (mAb 24), which has been used previously by us
[16,17] and others [8,18] to probe the activation status of
aMb2. Fig. 4D shows that expression of radixin N-ERMAD
signiﬁcantly increased mAb 24 binding to aMb2 (P = 0.002),
suggesting that in the presence of radixin N-ERMAD aMb2 ex-
ists in an active conformation. Thus, radixin N-ERMAD most
likely enhanced aMb2-mediated cell adhesion by activating the
receptor.4. Discussion
Talin is the only known FERM-containing protein capable
of integrin activation [1]. In this study, we identiﬁed another
FERM domain-containing protein radixin that exhibits similar
integrin activation capability. Compared to talin, radixin
exhibits two distinct features: ﬁrst, unlike talin, radixin recog-
nizes the membrane-proximal region but not the NPxY/F se-
quence within the integrin b cytoplasmic tail; and second,
talin but not radixin, is sensitive to calpain proteolysis and
1108 P. Tang et al. / FEBS Letters 581 (2007) 1103–1108activation [19]. Thus, radixin may function as a talin-indepen-
dent integrin activation pathway under speciﬁc settings.
Radixin interacts with the cytoplasmic domains of a number
of cell surface proteins, including ICAM-1, ICAM-2, ICAM-3,
CD44, and CD43 [20,21]. Though no consensus sequences
among these diﬀerent cytoplasmic domains have been identi-
ﬁed for radixin binding, most of the known radixin recognition
sequences reside within the membrane-proximal regions and
contain clusters of hydrophobic and positively charged resi-
dues [21]. Indeed, results from this study demonstrate that
radixin binds to the membrane-proximal region of integrin
b2, which shares a signiﬁcant homology with the radixin-recog-
nition sequence within ICAM-2, especially surrounding those
resides (shown in boxes, Fig. 5A) that are in direct contacts
with the PTB/F3 domain of radixin (Fig. 5B) [22]. Accord-
ingly, we hypothesize that the LxxLxxYRRF sequence within
the b2 cytoplasmic domain, a sequence that is homologous to
the radixin-binding site (YxxLxxWRRL) within ICAM-2, rep-
resents the major recognition site for radixin (Fig. 5B, con-
served residues are shown in balls and sticks). Experiments
to test this hypothesis are under way.
In summary, using a number of diﬀerent approaches, we have
established radixin as an important player in integrin activation.
Our data demonstrate that radixin is capable of binding and
activating the b2 integrin receptor, thus identifying radixin as
the second FERM-containing protein, in addition to talin, that
supports integrin ‘‘inside-out’’ signaling. As radixin and talin
recognize diﬀerent regions of the integrin cytoplasmic tail, and
are activated by independent intracellular signaling pathways,
for example, radixin is activated by Rho-dependent kinase
(ROCK) [23] and phosphatidylinositol 4-phosphate 5-kinase
[24], whereas talin is primarily activated by calpain-mediated
cleavage [2], radixin may represent a novel talin-independent
pathway for integrin activation under speciﬁc settings.
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